We performed survival analysis in HCC patients, and the results showed that a poor prognosis was linked to the high expression of USP5 and LSH (Figure S6C,D), and patients with high expression of both USP5 and LSH showed the worst prognosis (Figure 7E). The gene discussed is HELLS; the disease is hepatocellular carcinoma.